Lloyd-Smith Malcolm insider trades
Lloyd-Smith Malcolm has filed 6 Form 4s with the SEC that we hold, all for Neurocrine Biosciences INC (NBIX), as Chief Integration Officer. Across all of them we count 0 purchases worth $0 and 11 sales worth $5.9M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 21,533 shares of Neurocrine Biosciences INC worth $2.3M, dated 2022-08-12. The first filing on our record is dated 2021-07-29 and the latest 2023-02-08.
Neurocrine Biosciences INC (NBIX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-27 | S, sale reported on Form 4 | 16,709 | $1.6M | 2021-07-29 |
| 2022-02-07 | S, sale reported on Form 4 | 801 | $64.6K | 2022-02-09 |
| 2022-02-07 | S, sale reported on Form 4 | 1,015 | $81.9K | 2022-02-09 |
| 2022-02-07 | S, sale reported on Form 4 | 865 | $69.9K | 2022-02-09 |
| 2022-02-08 | S, sale reported on Form 4 | 701 | $55.8K | 2022-02-09 |
| 2022-08-12 | S, sale reported on Form 4 | 21,533 | $2.3M | 2022-08-16 |
| 2023-01-31 | S, sale reported on Form 4 | 1,666 | $183.3K | 2023-02-02 |
| 2023-02-06 | S, sale reported on Form 4 | 801 | $84.8K | 2023-02-08 |
| 2023-02-07 | S, sale reported on Form 4 | 12,801 | $1.3M | 2023-02-08 |
| 2023-02-07 | S, sale reported on Form 4 | 1,015 | $103.7K | 2023-02-08 |
| 2023-02-08 | S, sale reported on Form 4 | 701 | $72.8K | 2023-02-08 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1557146) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms